language_icon
EN
HI

Curis Lifesciences Share price

CURIS

112.95

2.05 (-1.78%)
Last updated on 2 Jun, 2026 | 15:31 IST
Today's High

113.00

Today's Low

112.00

52 Week Low

83.60

52 Week High

147.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Curis Lifesciences Chart

Curis Lifesciences Share Key Metrics

Volume
10000.00
Market Cap
91.31 CR
LTQ@LTP
1000@112.95
ATP
112.2
Var Margin
53.5 %
Circuit Range
92-138
Delivery %
84.62 %
Value
11.22 L
ASM/GSM
No
Market Lot
1000

Summary

Curis Lifesciences share price is ₹112.95 as of 3 Jun, 2026. The stock Curis Lifesciences intraday movement has stayed between ₹112.00 and ₹113.00, while on a 52-week basis,Curis Lifesciences price 52 week high is ₹147.90 & its 52 week low is ₹83.60.
In terms of trading activity, Curis Lifesciences has recorded a volume of 10000 shares, The Curis Lifesciences has a market cap of ₹8084434 CR. The stock’s Average Traded Price (ATP) stands at ₹112.20, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1000 @ ₹112.95.
Curis Lifesciences operates within a circuit range of ₹92.00 – ₹138.00, with a Value of ₹11.22 L. The Delivery Percentage for the day is 84.62%. Additionally, Curis Lifesciences currently falls under the No framework, and trades with a market lot size of 1000.

Curis Lifesciences Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.53

Sector P/B

2.99

Sec. Div. Yield

0.55

Curis Lifesciences Resistance and Support

Pivot 114.63

Resistance

First Resistance

117.26

Second Resistance

119.53

Third Resistance

122.16

Support

First Support

112.36

Second Support

109.73

Third Support

107.46

Curis Lifesciences Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

68.03%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.19%

Domestic Institutional Investors

4.35%

Retail

26.43%

Others

0%

Total Promoters
MAR '26
68.03%

Curis Lifesciences Corporate Actions

DateAgenda
2026-05-30Audited Results
2025-12-04Quarterly Results

Curis Lifesciences News

Curis Lifesciences Limited

Curis Lifesciences disclosed that Rs. 7.75 crore (28%) of its Initial Public Offering funds raised in November 2025 remain unutilized as of March 31, 2026. These funds were allocated for capital expenditure towards manufacturing facilities and a storage facility, as well as product registrations.
May 30 2026 21:20:38

Curis Lifesciences Limited

Curis Lifesciences board will meet on May 30, 2026, to consider and approve its audited annual financial results for the year ended March 31, 2026. This meeting will finalize the company's financial performance for the last fiscal year.
May 26 2026 13:17:20

Curis Lifesciences Limited

Curis Lifesciences board will convene on May 30, 2026, to review and approve the audited standalone financial results for the fiscal year ended March 31, 2026. The meeting will also cover the utilization of IPO proceeds.
May 26 2026 13:15:01

Eris Lifesciences Limited

Eris Lifesciences Limited declared an interim dividend of Rs. 7.21 per equity share for the financial year 2026-27. The record date for this dividend is May 29, 2026, with payment to be made by June 19, 2026.
May 20 2026 15:04:12

Eris Lifesciences Limited

Eris Lifesciences' subsidiary Eris Therapeutics had its bank loan facilities rated 'IND AA/Stable/IND A1+' by India Ratings. This includes a new assignment for INR 100 crore and affirmation for INR 420 crore, which was reduced from INR 469 crore.
May 12 2026 19:23:43

Eris Lifesciences Limited

India Ratings and Research (Ind-Ra) affirmed Eris Lifesciences's Long-term Issuer Rating and bank facilities at 'IND AA' with a Stable Outlook. This reflects the company's sustained healthy operating performance.
May 08 2026 17:05:28
Read More

Curis Lifesciences Management

NamePosition
Nikhil PurohitCompany Secretary & Compliance Officer
Dharmesh Dasharathbhai PatelChairman & Managing Director
View More

Curis Lifesciences Similar Stocks

No Data Found

Curis Lifesciences FAQs

The Buying Price of Curis Lifesciences share is 112.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Curis Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Curis Lifesciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Curis Lifesciences shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Curis Lifesciences shares is 0. Useful to assess the stock's value relative to its book value.

To assess Curis Lifesciences’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.

The Market Cap of Curis Lifesciences is 91.31 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Curis Lifesciences share price is 147.90 & 83.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Curis Lifesciences belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost